(00:32) Could you let our listeners know a bit about your role and background at Mayo Clinic?(01:23) Is there a lot of information sharing between our neurology clinicians and the Alzheimer’s Disease Research Center when it comes to test development?(01:50) Can you give us a brief overview of the test?(03:17) Is a cerebral spinal fluid test for NFLC already on the market?(04:41) How has Mayo Clinic been able to launch this test in blood? (05:49) What is a laboratory developed test, and what does it mean for physicians?(07:00) Do we have a high degree of confidence that physicians will get an actionable result from this blood test?(07:45) How will Mayo Clinic Laboratories help physicians interpret the test results?(09:15) For which patients is this test most appropriate?(10:59) How might patients benefit from this test?(11:46) How can this test help physicians to know which treatment path to pursue?(12:33) How else might this test benefit patients?(13:49) What about this test excites you most?

Ver todos los episodios